China Pharma Holdings Price to Free Cash Flow Ratio 2012-2026 | CPHI
Historical price to free cash flow ratio values for China Pharma Holdings (CPHI) since 2012.
| China Pharma Holdings Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2026-06-18 | 0.77 | 21.66 | |
| 2026-03-31 | 0.61 | $0.04 | 17.13 |
| 2025-12-31 | 1.21 | 0 | 0.00 |
| 2025-09-30 | 1.95 | $0.11 | 17.27 |
| 2025-06-30 | 1.79 | $0.19 | 9.42 |
| 2025-03-31 | 2.63 | $0.11 | 23.00 |
| 2024-12-31 | 2.33 | $-0.29 | 0.00 |
| 2024-09-30 | 2.36 | $0.07 | 34.00 |
| 2024-06-30 | 2.49 | $7.08 | 0.35 |
| 2024-03-31 | 3.71 | $6.20 | 0.60 |
| 2023-12-31 | 1.21 | $-2.10 | 0.00 |
| 2023-09-30 | 1.48 | $3.91 | 0.38 |
| 2023-06-30 | 3.41 | $-3.00 | 0.00 |
| 2023-03-31 | 3.90 | $-7.16 | 0.00 |
| 2022-12-31 | 9.59 | $-7.72 | 0.00 |
| 2022-09-30 | 13.00 | $-16.43 | 0.00 |
| 2022-06-30 | 21.46 | $-26.00 | 0.00 |
| 2022-03-31 | 39.00 | $-13.72 | 0.00 |
| 2021-12-31 | 48.26 | $-7.46 | 0.00 |
| 2021-09-30 | 55.85 | $1.27 | 43.85 |
| 2021-06-30 | 72.32 | $5.18 | 13.95 |
| 2021-03-31 | 84.00 | $-6.67 | 0.00 |
| 2020-12-31 | 44.58 | $-10.43 | 0.00 |
| 2020-09-30 | 36.48 | $-17.78 | 0.00 |
| 2020-06-30 | 66.63 | $-6.86 | 0.00 |
| 2020-03-31 | 50.39 | $2.19 | 23.03 |
| 2019-12-31 | 23.68 | $5.42 | 4.37 |
| 2019-09-30 | 24.51 | $16.08 | 1.52 |
| 2019-06-30 | 32.34 | $20.80 | 1.55 |
| 2019-03-31 | 33.18 | $11.48 | 2.89 |
| 2018-12-31 | 25.74 | $21.01 | 1.23 |
| 2018-09-30 | 20.42 | $21.13 | 0.97 |
| 2018-06-30 | 21.99 | $18.64 | 1.18 |
| 2018-03-31 | 31.71 | $14.25 | 2.23 |
| 2017-12-31 | 17.56 | $8.09 | 2.17 |
| 2017-09-30 | 17.50 | $13.81 | 1.27 |
| 2017-06-30 | 23.00 | $15.93 | 1.44 |
| 2017-03-31 | 26.00 | $16.31 | 1.59 |
| 2016-12-31 | 26.00 | $31.00 | 0.84 |
| 2016-09-30 | 21.50 | $41.97 | 0.51 |
| 2016-06-30 | 24.00 | $45.14 | 0.53 |
| 2016-03-31 | 17.00 | $45.64 | 0.37 |
| 2015-12-31 | 15.69 | $30.57 | 0.51 |
| 2015-09-30 | 19.84 | $15.56 | 1.27 |
| 2015-06-30 | 35.99 | $0.90 | 40.18 |
| 2015-03-31 | 34.00 | $-0.66 | 0.00 |
| 2014-12-31 | 30.01 | $-14.58 | 0.00 |
| 2014-09-30 | 25.09 | $-79.34 | 0.00 |
| 2014-06-30 | 38.50 | $-175.97 | 0.00 |
| 2014-03-31 | 50.50 | $-139.57 | 0.00 |
| 2013-12-31 | 34.50 | $-117.01 | 0.00 |
| 2013-09-30 | 28.00 | $-63.83 | 0.00 |
| 2013-06-30 | 21.00 | $35.07 | 0.60 |
| 2013-03-31 | 29.00 | $34.13 | 0.85 |
| 2012-12-31 | 20.20 | $21.50 | 0.94 |
| 2012-09-30 | 36.50 | $18.69 | 1.95 |
| 2012-06-30 | 34.00 | $38.21 | 0.89 |
| 2012-03-31 | 68.00 | $36.35 | 1.87 |
| 2011-12-31 | 67.00 | $56.17 | 1.19 |
| 2011-09-30 | 97.00 | $80.34 | 1.21 |
| 2011-06-30 | 225.00 | $91.15 | 2.47 |
| 2011-03-31 | 253.00 | $91.74 | 2.76 |
| 2010-12-31 | 303.00 | $88.69 | 3.42 |
| 2010-09-30 | 249.00 | $119.23 | 2.09 |
| 2010-06-30 | 275.00 | $127.49 | 2.16 |
| 2010-03-31 | 333.00 | $129.67 | 2.57 |
| 2009-12-31 | 385.00 | $124.48 | 3.09 |
| 2009-09-30 | 340.00 | $54.15 | 6.28 |
| 2009-06-30 | 145.00 | $72.79 | 1.99 |
| 2009-03-31 | 131.00 | $14.47 | 9.05 |
| 2008-12-31 | 114.00 | $27.76 | 4.11 |
| 2008-09-30 | 208.00 | $84.67 | 2.46 |
| 2008-06-30 | 202.00 | $42.20 | 4.79 |
| 2008-03-31 | 230.00 | $77.71 | 2.96 |
| 2007-12-31 | 305.00 | $26.52 | 11.50 |
| 2007-09-30 | 180.00 | $-5.18 | 0.00 |
| 2007-06-30 | 170.00 | $-51.32 | 0.00 |
| 2007-03-31 | 188.00 | $-51.68 | 0.00 |
| 2006-12-31 | 227.00 | $-27.63 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Generic Drugs | $0.026B | $0.004B |
| CHINA PHARMA HOLDINGS, Inc. develops, manufactures, and markets generic and brand bio-pharmaceutical products in China that treat a wide range of conditions, including infections, hepatitis, cardiovascular and CNS diseases, and other prevailing diseases. Helpson Bio-pharmaceutical Co., Ltd. (Helpson), a specialty pharmaceutical company headquartered in Haikou City, Hainan province in China, is a wholly owned subsidiary of China Pharma Holdings. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | Israel | $35.437B | 10.97 |
| BridgeBio Pharma (BBIO) | United States | $14.460B | 0.00 |
| Dr Reddy's Laboratories (RDY) | India | $11.109B | 17.29 |
| Aspen Pharmacare (APNHY) | South Africa | $3.708B | 0.00 |
| Supernus Pharmaceuticals (SUPN) | United States | $2.918B | 22.33 |
| Bausch Health Cos (BHC) | Canada | $2.086B | 1.50 |
| Taysha Gene Therapies (TSHA) | United States | $1.290B | 0.00 |
| Amphastar Pharmaceuticals (AMPH) | United States | $0.924B | 7.28 |
| Personalis (PSNL) | United States | $0.630B | 0.00 |
| Assembly Biosciences (ASMB) | United States | $0.451B | 0.00 |
| Sol-Gel Technologies (SLGL) | Israel | $0.210B | 0.00 |
| Metagenomi Therapeutics (MGX) | United States | $0.052B | 0.00 |
| Evoke Pharma (EVOK) | United States | $0.019B | 0.00 |
| Teligent (TLGT) | United States | $0.000B | 0.00 |